als — grants · GrantIndex

Sort

38,696 grants matching “als”

Inhibiting P13K p110B to block cocaine-induced habits and drug seeking

$399,491

Shannon Leigh Gourley · Emory University · R01 · FY2019 · DA

Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.

$399,489

Michael Benatar · University Of Miami School Of Medicine · R01 · FY2011 · FD

Creating a disease-agnostic scalable platform for decentralized observational and validation of digital biomarkers studies and piloting it for people with familial ALS and ultra-rare MNDs

$399,466

Alexander V Sherman · Massachusetts General Hospital · U01 · FY2025 · FD

Mapping the Genes for Ethanol Related Phenotypes

$399,458

Oregon Health And Science University · R01 · FY2005 · AA

Evaluating Use and Expenditures on Low Quality Breast Cancer Care in the Medicare Program

$399,452

Jean M Mitchell · Georgetown University · R01 · FY2025 · HS

Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.

$399,424

Michael Benatar · University Of Miami School Of Medicine · R01 · FY2013 · FD

PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS

$399,396

Duke University · R01 · FY2003 · AG

YBMSM's Sexual Communication with Friends in Two Culturally Distinct U.S. Regions

$399,382

Matt Gary Mutchler · California State Univ-Dominguez Hills · R15 · FY2012 · MH

Functional Activity Mapping of Brain Networks

$399,362

Carol A. Barnes · University Of Arizona · RC1 · FY2010 · AG

Project 5 The causal role of neocortical beta events in human sensory perception

$399,281

Stephanie Ruggiano Jones · Brown University · P20 · FY2021 · GM

Inhibiting P13K p110B to block cocaine-induced habits and drug seeking

$399,277

Shannon Leigh Gourley · Emory University · R01 · FY2020 · DA

Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination

$399,261

Jonah R Chan · University Of California, San Francisco · R01 · FY2022 · NS

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258

Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2019 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258

Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2022 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258

Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2020 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258

Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2021 · GM

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

$399,258

Glen Traver Hart · University Of Tx Md Anderson Can Ctr · R35 · FY2018 · GM

Creating a disease-agnostic scalable platform for decentralized observational and validation of digital biomarkers studies and piloting it for people with familial ALS and ultra-rare MNDs

$399,250

Alexander V Sherman · Massachusetts General Hospital · U01 · FY2024 · FD

A Computational Tool for Modeling of Protein Macromolecules Guided by Cryo-Electron Microscopy Data

$399,245

Kamal Al Nasr · Tennessee State University · R15 · FY2017 · GM

A fully automated tool for more accurate malignancy assessment in pulmonary nodules from chest CT

$399,112

Joshua Reicher · Imvaria Inc. · R43 · FY2025 · CA

IRF4+ respiratory dendritic cells in type 2 inflammatory responses

$399,048

Anne I. Sperling · University Of Chicago · R01 · FY2019 · AI

Inhibiting P13K p110B to block cocaine-induced habits and drug seeking

Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.

Creating a disease-agnostic scalable platform for decentralized observational and validation of digital biomarkers studies and piloting it for people with familial ALS and ultra-rare MNDs

Mapping the Genes for Ethanol Related Phenotypes

Evaluating Use and Expenditures on Low Quality Breast Cancer Care in the Medicare Program

Phase II/III Study of Arimoclomol in the Treatment of SOD1 Positive Familial?.

PHARMACOLOGY OF VASCULAR AL-ADRENERGIC RECEPTORS

YBMSM's Sexual Communication with Friends in Two Culturally Distinct U.S. Regions

Functional Activity Mapping of Brain Networks

Project 5 The causal role of neocortical beta events in human sensory perception

Inhibiting P13K p110B to block cocaine-induced habits and drug seeking

Neuropeptides as axonal determinants for oligodendrocyte differentiation and myelination

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

EXPLOITING PATTERNS OF GENE ESSENTIALITY IN HUMAN CELLS TO PREDICT GENE FUNCTION, SYNTHETIC LETHALITY, AND CANCER TARGETS

Creating a disease-agnostic scalable platform for decentralized observational and validation of digital biomarkers studies and piloting it for people with familial ALS and ultra-rare MNDs

A Computational Tool for Modeling of Protein Macromolecules Guided by Cryo-Electron Microscopy Data

The Role of Carboxypeptidase B and its Substrates in Rheumatoid Arthritis

Nicotine and Alcohol Co-Dependence

Nicotine and Alcohol Co-Dependence

The Role of Carboxypeptidase B and its Substrates in Rheumatoid Arthritis

A fully automated tool for more accurate malignancy assessment in pulmonary nodules from chest CT

IRF4+ respiratory dendritic cells in type 2 inflammatory responses